ISTO Biologics (ISTO), a Thompson Street Capital Partners (TSCP) portfolio company, today announced that it has acquired Progenicare LLC., (Progenicare) of Austin, Texas. Progenicare is a manufacturer’s representative and distributor of medical devices and solutions used primarily in orthopedic and cardiac medicine applications. Terms of the sale were not disclosed.
Progenicare (www.progenicare.com) is a leading provider of biologic products for various regenerative applications, focusing on orthopedic, spine, vascular, and cosmetic indications.
Said Anthony Chambers, Director at Thompson Street Capital Partners, “We’re delighted to welcome Progenicare, with its vast clinical expertise, best-in-class medical education team and OR services, to the ISTO Biologics fold.” Added Mr. Chambers, “Both ISTO and Progenicare have been remarkably successful with their innovative product offerings. This addition to our portfolio will allow ISTO to greatly expand its footprint within the biologics sphere.”